is expressed tissue specifically in the lung and is developmentally regulated. To identify genomic regions that control SP-B expression, we analyzed SP-B promoter activity in transgenic mice containing rabbit SP-B 5Ј-flanking DNA fragments linked to the chloramphenicol acetyltransferase (CAT) reporter gene. Results showed that whereas the Ϫ2,176/ϩ39-bp fragment failed to express CAT, shorter fragments of Ϫ730/ϩ39 and Ϫ236/ϩ39 bp expressed CAT tissue specifically in the lung. Further deletion of 5Ј-flanking DNA to Ϫ136 bp resulted in no expression of CAT. Immunostaining demonstrated that both Ϫ730/ϩ39-and Ϫ236/ϩ39-bp regions expressed CAT specifically in alveolar type II and Clara cells. The Ϫ236/ϩ39-bp region expressed CAT at a significantly lower level than the Ϫ730/ϩ39-bp region. CAT expression in mice containing the Ϫ730/ϩ39-bp region was detected in embryonic day 14 lung and attained maximum levels in day 18 lung, indicating that the developmental expression of CAT was similar to that of SP-B. These data show that the DNA elements necessary for cell type-specific expression are located within Ϫ236/ϩ39 bp of the SP-B gene. Additionally, these data suggest that the Ϫ2,176/Ϫ730-and Ϫ730/Ϫ236-bp regions contain the DNA elements that repress and enhance
of the biophysical properties and physiological functioning of surfactant. SP-B promotes the adsorption and spreading of surfactant phospholipids (22) and stabilizes the phospholipid monolayer formed on the alveolar surface (8) . Deficiency of SP-B due to a frame shift mutation in the coding region is associated with fatal respiratory failure in infants with congenital alveolar proteinosis (18) . Targeted disruption of the SP-B gene causes respiratory failure in newborn mice, further supporting the important role of SP-B in lung function (7) .
SP-B mRNA is expressed in a cell type-specific manner by the alveolar type II and bronchiolar epithelial cells of the lung (20, 30) and is under developmental and multifactorial regulation (28) . Glucocorticoids and cAMP increase, whereas tumor necrosis factor-␣ decreases SP-B mRNA expression (3) .
Our laboratory (15) previously found that a minimal promoter containing Ϫ236/ϩ39 bp of rabbit SP-B gene is necessary and sufficient for high-level expression of the chloramphenicol acetyltransferase (CAT) reporter gene in NCI-H441 cells, a cell line with the characteristics of bronchiolar epithelial cells (Clara cells). The minimal SP-B promoter supported high-level CAT expression in a lung cell type-specific manner in cell cultures, suggesting that it contained a cell-or tissuespecific enhancer (15) . Our studies also identified binding sites for Sp1, Sp3, thyroid transcription factor-1 and hepatocyte nuclear factor-3 transcription factors in the minimal SP-B promoter that acted in a cooperative or combinatorial manner to maintain SP-B promoter activity (16) .
Genomic regions and gene regulatory elements that direct cell-specific and developmental expression of the SP-B gene have not been identified. In this study, we analyzed SP-B promoter activity in mice containing SP-B 5Ј-flanking DNA fragments linked to the CAT gene. Analysis of CAT expression in transgenic mice showed that, whereas the Ϫ2,176/ϩ39-bp region failed to support CAT expression, shorter fragments consisting of Ϫ730/ϩ39 and Ϫ236/ϩ39 bp expressed CAT in a cell-or tissue-specific manner in the lung. Further deletion of 5Ј-flanking DNA to Ϫ136 bp resulted in no expression of CAT in lung and other tissues. CAT expression was restricted to alveolar type II and bronchiolar (Clara) epithelial cells. The developmental expression of CAT in mice containing the Ϫ730/ϩ39-bp region of the SP-B gene was similar or identical to endogenous SP-B gene expression.
EXPERIMENTAL PROCEDURES
Plasmid construction and generation of transgenic mice. Plasmid pBLCAT6 containing the Ϫ2,176/ϩ39-bp fragment of the SP-B gene was digested with HindIII and KpnI or SacI to release SP-B-CAT fusion DNA constructs containing Ϫ2,176/ϩ39-and Ϫ730/ϩ39-bp fragments of the SP-B gene. Plasmid pSKCAT containing the Ϫ236/ϩ39-bp fragment of the SP-B gene was digested with XbaI and KpnI to release a SP-B-CAT fusion DNA construct containing the Ϫ236/ ϩ39-bp fragment of the SP-B gene. Plasmid pBLCAT6 containing Ϫ136/ϩ39 bp of SP-B 5Ј-flanking DNA was digested with HindIII and KpnI to obtain a SP-B-CAT construct containing the Ϫ136/ϩ39-bp SP-B fragment. The linear SP-B-CAT fusion DNA fragments were purified by agarose gel electrophoresis and dissolved in 10 mM Tris ⅐ HCl, pH 7.4, at a concentration of ϳ100 ng/ml. Transgenic mice were generated at the Transgenic Technology Core Facility (University of Texas Southwestern Medical Center, Dallas, TX). Transgenic offspring were identified by dot blot analysis of tail DNA with the use of full-length CAT cDNA as a probe. The number of copies (c) of transgene integrated per genome of transgenic mice was determined by quantitative DNA dot blot assay, with CAT cDNA as the standard.
Dot and Southern blot analysis of tail DNA. Genomic DNA from mouse tails (0.6-1 cm) was isolated with a DNA isolation kit from 5 Prime 3 3 Prime (Boulder, CO) or QIAGEN (Valencia, CA), and the DNA concentration was determined by measuring absorbance at 260 nm. Dot and Southern blot analyses of DNA were carried out according to standard methods with 5-10 g of genomic DNA and Hybond Nϩ (Amersham) as the transfer membrane. The membranes were hybridized with 32 P-labeled full-length CAT cDNA as the probe, washed under high-stringency conditions, and exposed to X-ray film to obtain an autoradiograph.
CAT enzymatic assay and CAT ELISA. Mouse tissues were suspended in 5 volumes (vol/wt) of cold 0.25 M Tris ⅐ HCl, pH 7.8, containing 0.5 mM phenylmethylsulfonyl fluoride, 2 g/ml of aprotinin and leupeptin, and 0.5 g/ml of benzamidine and homogenized with a high-speed homogenizer (Tekmar Tissuemizer). Homogenates were freeze-thawed and centrifuged at 12,000 g for 5 min, and the supernatants were removed and stored at Ϫ70°C. The CAT activity of the tissue extracts was determined by the liquid scintillation counting method (24) after the extracts were heated to 60°C for 10 min to inactivate the endogenous acetylase. CAT levels were also measured by ELISA with a CAT ELISA kit (Boehringer Mannheim).
Determination of protein. The protein concentration of the tissue extracts was determined by the Bradford (5) method with the Bio-Rad protein assay reagent and bovine serum albumin as the protein standard.
RNA isolation and Northern blot analysis. Total RNA from tissues was isolated by the acid-phenol method with TRI Reagent (Molecular Research Center, Cincinnati, OH) according to the manufacturer's instructions. The RNA was separated by electrophoresis on agarose gels (1%) containing 20 mM MOPS and 1.1% formaldehyde and transferred to Hybond Nϩ membranes by capillary action with salinesodium citrate (20ϫ) as the transfer solution. The membranes were hybridized with 32 P-labeled full-length mouse SP-B cDNA and CAT cDNA probes, washed, and exposed to X-ray film to obtain an autoradiograph.
Immunohistochemical localization of CAT and SP-B. Adult mice were killed, and their lungs were perfused with saline to remove blood. The perfused lungs were instilled with formalin or ExCell fixative for 20 min under 20 cmH 2 O pressure and then removed and stored in the fixative for 24 h. The fixed lungs were dehydrated and embedded in paraffin, and serial 6-m sections were cut for histology. Tissue sections were serially incubated with polyclonal CAT (5 Prime 3 3 Prime), human SP-B (Chemicon International, Temecula, CA), or nonimmune IgG antibodies at 1:200 dilution; biotinylated secondary antibody; and horseradish peroxidase-labeled streptavidin (Innovex Biosciences, Richmond, CA). Sections were then stained with 3-amino-9-ethylcarbazole (AEC) according to the kit instructions and counterstained with hematoxylin. For double immunostaining, the sections were stained first with AEC for CAT and then with TrueBlue substrate (Kirkegaard and Perry, Gaithersburg, MD) for SP-B.
Developmental regulation of CAT. F 1 heterozygous male transgenic mice were mated with wild-type female mice, and the female mice were examined daily for the copulatory plug. The gestational age of the embryos was estimated based on the day that the copulatory plug was first detected in the female (day 0). The female mice were killed at different stages of gestation, and the embryos were collected. Lungs were removed for the preparation of extracts with the aid of a dissecting microscope.
Cell culture and transfections. MLE-12 cells, a mouse lung epithelial cell line, were maintained in HITES (hydrocortisone, insulin, transferrin, estrogen, and selenium) medium containing penicillin (100 U/ml) and streptomycin (100 g/ ml) and supplemented with 2% fetal bovine serum. These cells express detectable levels of SP-B and SP-C and therefore may have characteristics of alveolar type II cells (29) . MLE-12 cells were transfected by liposome-mediated DNA transfer with LipofectAMINE. The conditions for transfection were similar to those previously described for NCI-H441 cells by our laboratory (15) .
RESULTS

Generation of SP-B-CAT transgenic mice.
To identify the genomic regions that control cell type-specific and developmental expression of the SP-B gene, we constructed SP-B-CAT fusion genes containing Ϫ2,176/ ϩ39-, Ϫ730/ϩ39-, Ϫ236/ϩ39-, and Ϫ136/ϩ39-bp fragments of rabbit SP-B 5Ј-flanking DNA (Fig. 1) . The SP-B-CAT fusion DNA constructs were injected into mouse oocytes to generate transgenic mice, and the transgenic founder mice were bred with wild-type mice to establish independent lines of transgenic mice.
Expression of CAT in transgenic mice. We analyzed SP-B promoter activity in transgenic mice by measuring tissue expression of CAT activity (Table 1) . Results showed that CAT activity was not detected in the lung extracts of mice from seven independent lines derived from the Ϫ2,176/ϩ39-CAT construct. Analysis of CAT activity in other tissues, such as liver, kidney, intestine, stomach, trachea, spleen, heart, and skeletal muscle, in mice from two independent lines indicated the absence of CAT expression. Tissue-specific expression of CAT was also analyzed by Northern blotting. Consistent with the results of tissue expression of CAT activity, Northern blot analysis showed no expression of CAT mRNA in lung and other tissues (data not shown). These data indicated that the Ϫ2,176/ϩ39-bp region of the SP-B gene is not capable of directing CAT expression in lung or other tissues.
To determine if the lack of transgene expression was due to an alteration of the introduced transgene by degradation or rearrangement, we determined the size of the transgene integrated into the genome by Southern blot analysis. Tail DNA of seven independent lines of mice was digested with EcoRI (EcoRI cuts the transgene at nucleotide 303 of CAT cDNA) and analyzed by Southern blotting with 32 P-labeled CAT cDNA. Results indicated that a DNA fragment of ϳ4 kb was hybridized in the DNA digests of mice containing more than one copy of the transgene (data not shown). These data are consistent with the integration of the intact transgene linked in a tandem head-to-tail array at the site of integration and rule out degradation or rearrangement of the transgene. It is a common finding in transgenic mice that when multiple copies integrate, they are always found linked in a tandem head-to-tail array at the site of integration (19) . Analysis of CAT expression in F 1 heterozygous mice from three independent lines derived from the Ϫ730/ ϩ39-CAT construct revealed that CAT activity was expressed in a tissue-specific manner in the lung (Table 1). CAT activity in other tissues examined was not significantly higher than background, indicating lack of expression. Transgenic line 1, with three to six copies of the transgene, expressed CAT at a significantly higher level than the other lines (Table 1) . Tissue-specific expression of CAT activity in an adult F 1 heterozygous mouse from line 1 (3-6 c) is shown in Fig. 2 . Southern blot analysis of tail DNA from transgenic line 1, with 32 P-labeled CAT cDNA indicated that the integrated transgene had not undergone any degradation or rearrangement (data not shown). Of the four independent lines of mice that were positive for the Ϫ236/ϩ39-bp construct, only one line (line 3) expressed CAT in a tissue-specific manner in the lung. CAT activity in the other tissues was similar to that in corresponding tissues of a wild-type littermate and was considered background. The Ϫ236/ϩ39-bp region expressed CAT at a significantly lower level compared with the Ϫ730/ϩ39-bp region (Table 1) . CAT activity was not detected in lung and other tissues from four independent lines of mice derived from the Ϫ136/ ϩ39-bp construct, indicating the inability of the Ϫ136/ ϩ39-bp SP-B region to direct expression.
Tissue-specific expression of CAT mRNA. Because CAT expression in mice (3-6 c) derived from the Ϫ730/ 
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Chloramphenicol acetyltransferase (CAT) activity data are averages of 2 independent measurements and correspond to different mice in a given transgenic (TG) line, SP-B, surfactant protein B; cpm, counts/min; ND, not detected. Other tissues include heart, intestine, kidney, liver, muscle, stomach, spleen, and trachea.
ϩ39-CAT transgene was highest compared with the other lines, we analyzed tissue-specific expression of CAT mRNA by Northern blotting. Results showed that similar to the endogenous SP-B mRNA, CAT mRNA expression was detected only in the lung (Fig. 3) .
Western blot analysis of the tissue extracts of transgenic mice with polyclonal antibodies to CAT identified a protein of 24 kDa in the lung extracts, which was consistent with the results of the Northern blot analysis (data not shown). No protein of similar size was detected in the lung extracts of a wild-type littermate.
Cellular expression of the CAT transgene. SP-B mRNA is expressed in the alveolar type II and bronchiolar epithelial cells of adult lungs (20, 30) . In the adult rabbit lung, approximately equal concentrations of SP-B mRNA were detected in alveolar type II and bronchiolar epithelial cells (30) 
Results for the Ϫ730/ϩ39-bp transgenic mice showed that the majority of alveolar epithelial cells that expressed SP-B were located at the corners of the alveoli (Fig. 4A) . Immunostaining for CAT was also found predominantly in alveolar epithelial cells located at the corners of the alveoli (Fig. 4B) . Nearly all of the cells lining the bronchiolar epithelium stained positive for SP-B (Fig. 4C) and CAT (Fig. 4D) . Staining for CAT was not detected in lung tissues of wild-type littermates (Fig. 4, E and F) . Tissue sections stained with nonimmune IgG showed little or no reaction, indicating low background (data not shown). Double immunostaining showed that many but not all of the cells that stained positive for CAT also stained for SP-B (data not shown). The extensive staining for SP-B and CAT in the bronchiolar epithelium was consistent with the finding that Clara cells comprise 90% of the total cell population in the bronchiolar epithelium (21) . Staining for CAT was detected in the alveolar type II and bronchiolar (Clara) epithelial cells of Ϫ236/ϩ39-bp SP-B transgenic mice, but the intensity was less compared with Ϫ730/ϩ39-bp transgenic mice (data not shown).
Developmental expression of CAT mRNA. We investigated the developmental expression of CAT to determine if the Ϫ730/ϩ39-bp region of the SP-B gene was capable of controlling the developmental expression of the CAT gene in a manner similar to that in the endogenous SP-B gene. CAT expression in the lungs of embryonic day 14, 15, 16 , and 18 and newborn transgenic mice was analyzed by CAT assay to investigate the developmental regulation of CAT expression (Fig.  5) . CAT expression was detected in embryonic day 14 lungs and increased markedly as a function of development to reach maximal levels by embryonic day 18. The expression levels of CAT in newborn mice were not significantly different from those in embryonic day 18 mice. Investigation of the developmental expression of CAT by ELISA produced similar results (data not shown). The levels of CAT expression in embryonic lungs in a given family varied considerably even though they were expected to have identical sites of integration and copy numbers of the transgene.
Analysis of SP-B promoter function in MLE-12 cells.
Immunostaining of lung tissues from mice containing the Ϫ236/ϩ39-bp region of the SP-B promoter demonstrated staining for CAT in both alveolar type II and Clara cells, although the intensity of staining was less than that in the mice containing the Ϫ730/ϩ39-bp region. These data suggested that cis-DNA elements within Ϫ236 bp are capable of directing transgene expression in both alveolar type II and Clara cells. We analyzed SP-B promoter function in MLE-12 cells by deletion mapping to determine if SP-B promoter fragments confer a pattern of regulation similar to that in NCI-H441 cells and transgenic mice. The results showed that deletion of the 5Ј-flanking SP-B DNA from Ϫ2,176 to Ϫ730 and Ϫ236 bp increased promoter activity by 30%; however, further deletion to Ϫ136 bp reduced activity by Ͼ80% (Fig. 6) . The pattern of SP-B promoter regulation in MLE-12 cells is similar to that observed in H441 cells (15) , suggesting that the cis-DNA elements that control promoter activity in H441 cells also control its activity in MLE-12 cells.
DISCUSSION
SP-B mRNA is expressed in a highly cell type-specific manner by the alveolar type II and bronchiolar epithelial cells of the lung (20, 29) . Although analysis of SP-B promoter expression by transfection studies has indicated that promoter fragments of human (4, 27) , rabbit (15) , and mouse (6) SP-B genes contain the cis-DNA elements necessary for cell-specific expression, their role in conferring lung cell-specific expression has not been investigated. Furthermore, the regulatory DNA regions that control developmental expression of the SP-B gene have not been identified.
Our laboratory previously determined (15) that rabbit SP-B 5Ј-flanking DNA sequences within Ϫ2,176 bp are capable of expressing the CAT reporter gene in NCI-H441 cells and that a minimal promoter sequence comprising Ϫ236/ϩ39 bp was necessary and sufficient for high-level expression of the CAT gene. In the present study, we analyzed SP-B promoter activity in transgenic mice to identify the DNA regions necessary for cell-specific and developmental regulation of expression. Transgene expression was not detected in lung and other tissues of several independent lines of mice harboring the Ϫ2,176/ϩ39-bp region of the SP-B gene. The lack of expression of the transgene may not be related to the site of integration or the copy number of the transgene because similar results were found in mice derived from seven independent lines. Although we did not determine the site of integration of the transgene in each line, it is highly likely that each line had a unique integration site because the microinjected DNA integrates randomly in individual embryos (19) . Southern blot analysis did not indicate modification of the injected DNA by degradation or rearrangement. Taken together, these data indicated that the Ϫ2,176/ϩ39-bp sequence of the SP-B gene is not capable of expressing the transgene.
The inability of the Ϫ2,176/ϩ39-bp region of the SP-B gene to express CAT suggests the presence of silencer elements within the Ϫ2,176-bp sequence. These DNA elements can bind transcriptional repressors to promote closed chromatin structure, leading to the inhibition of gene transcription. Our previous transfection study (15) showed that deletion of the Ϫ2,176-bp fragment of SP-B 5Ј-flanking DNA to Ϫ730 and Ϫ236 bp increased CAT expression by nearly twofold (15) , suggesting the existence of putative silencer elements in the upstream region. The results from transgenic mice are consistent with the data from transfection studies that indicate the presence of putative silencer elements within the Ϫ2,176/Ϫ730-bp region of SP-B 5Ј-flanking DNA.
Because the Ϫ2,176/ϩ39-bp region of SP-B 5Ј-flanking DNA failed to express the CAT gene in the transgenic mice, we sought to determine if shorter fragments of SP-B 5Ј-flanking DNA, Ϫ730/ϩ39 and Ϫ236/ ϩ39 bp, were capable of expressing CAT gene in the transgenic mice. Our laboratory showed in a previous study (15) that a minimal promoter region comprising Ϫ236/ϩ39 bp of the SP-B gene supported high-level expression of the CAT reporter gene in H441 cells. CAT expression was detected in a tissue-specific manner in the lungs of all three independent lines of transgenic mice harboring the Ϫ730/ϩ39-bp region. These data indicated that cis-acting DNA elements within the Ϫ730/ϩ39-bp region of SP-B gene 5Ј-flanking DNA are capable of directing tissue-specific expression of the CAT gene in the lung. Because all three independent lines of transgenic mice expressed CAT specifically in the lung, the findings cannot be related to the integration site or the copy number of the transgene.
The Ϫ236/ϩ39-bp SP-B region expressed CAT at a significantly lower level than the Ϫ730/ϩ39-bp region. Consistent with these data, immunohistochemical staining showed diminished CAT expression in alveolar type II and Clara cells of Ϫ236/ϩ39-bp transgenic mice. As in the case of the Ϫ730/ϩ39-bp construct, CAT activity was not detected in any tissue examined except lung, indicating that strict tissue-specific control of expression was maintained. Further deletion of the SP-B promoter to Ϫ136 bp resulted in no expression of CAT. These data are consistent with the results of our previous cell transfection study (15) that demonstrated the presence of the cis-DNA elements necessary for lung cell-specific expression within the Ϫ236/ϩ39-bp region of the SP-B gene.
SP-B promoter function was regulated similarly in both H441 cells and MLE-12 cells, suggesting that the same cis-DNA elements control cell-specific expression of the SP-B promoter in alveolar type II and Clara cells. This conclusion is further supported by the deletion mapping studies of SP-B promoter function in transgenic mice. The markedly lower expression of CAT in mice harboring the Ϫ236/ϩ39-bp construct compared with the Ϫ730/ϩ39-bp construct suggested that sequences within the Ϫ730/Ϫ236-bp region contain enhancer elements necessary for the optimal expression of SP-B promoter activity. The lack of CAT expression from the Ϫ136/ϩ39-bp region indicates that upstream sequences contain important cis-DNA elements and is consistent with the results of in vitro transfection studies that showed that the Ϫ236/ Ϫ136-bp region contains functional cis-DNA elements for thyroid transcription factor-1 and Sp1/Sp3 binding (14) . cis-DNA elements within Ϫ236/Ϫ136-and Ϫ136/ Ϫ27-bp regions are necessary for SP-B promoter activity in H441 cells in vitro (14, 15) .
The promoter activity of the Ϫ236/ϩ39-bp region in transgenic mice was significantly lower compared with the activity we (15) previously observed in NCI-H441 cells in vitro. The relatively low level of expression of the Ϫ236/ϩ39-bp promoter in transgenic mice could be due to the loss of upstream enhancer elements that were not detected in the in vitro cell culture system. Alternatively, the differences in the promoter activities between the in vitro (transient expression) and in vivo (transgenic animal) systems may be related to the state of the introduced DNA. Whereas the DNA was not integrated into the chromosome under conditions of the transient expression assay, it was stably integrated into the chromosome in transgenic mice. Because CAT expression was detected in both alveolar type II and Clara cells of mice containing the Ϫ236/ϩ39-bp region, albeit at lower levels compared with the mice containing the Ϫ730/ϩ39-bp region, the decrease in promoter activity could not have been due to the loss of type II cell-specific enhancer elements but rather due to the loss of enhancer elements that increase expression in both alveolar type II and Clara cells.
Genomic DNA regions that control cell-or tissuespecific and developmental regulation of other genes that are expressed in the pulmonary epithelium, such as Clara cell secretory protein (CCSP), SP-C, and SP-A, have recently been identified. A 2.25-kb fragment of the 5Ј-flanking region of the rat CCSP gene directed lung-and Clara cell-specific expression of the human growth hormone (hGH) reporter gene (12) . In a separate study (13) , a Ϫ2,338/ϩ49-bp fragment of 5Ј-flanking DNA of the rat CCSP gene directed expression of the CAT reporter gene in the lungs and tracheae of transgenic mice (25) . Although the CCSP genomic DNA fragment maintained Clara cell-specific expression of the hGH reporter gene, the developmental expression of the transgene was not maintained (13) . In other studies, it was found that even though the Ϫ166-bp region of the mouse CCSP gene was sufficient to direct Clara cell-specific expression of the transgene, enhancer sequences between the Ϫ803-and Ϫ166-bp regions were required for maximal expression of the transgene (23) . As little as 215 bp of human SP-C 5Ј-flanking DNA were found to be capable of directing alveolar type II cell-specific expression of CAT gene (10) .
A DNA fragment consisting of 378 bp of 5Ј-flanking DNA of the rabbit SP-A gene directed hGH expression in alveolar type II and bronchiolar epithelial cells of transgenic mouse lungs (1) . The DNA fragment also specified appropriate developmental regulation of the hGH gene (1) . However, ectopic expression of the hGH gene was detected in heart, thymus, and spleen. Sequences upstream of the 378-bp region, Ϫ4,000/Ϫ991 bp, appeared to be required to prevent ectopic expression while maintaining lung-specific expression of the hGH gene (1) .
In the present study, we found that the developmental expression of CAT activity was similar or identical to the expression of the endogenous SP-B mRNA (9) . SP-B mRNA was detected in embryonic day 15 lung, and its levels increased markedly thereafter to reach maximal levels in embryonic day 18 lung (6). These data suggested that the SP-B genomic fragment Ϫ730/ ϩ39 bp contains necessary information to specify appropriate developmental regulation of CAT expression. CAT expression levels during development varied within members of a given family. The exact reasons for the variation in CAT expression levels within a family are not clear but may be caused by integration of the transgene at more than one site in the genome.
Immunostaining experiments demonstrated CAT expression in cells localized at the corners of the alveoli and in cells lining the bronchiolar epithelium in a manner similar to the expression of endogenous SP-B. Because alveolar type II cells are predominantly located at the corners of the alveoli (17) and Clara cells (21) make up the majority of cells lining the bronchiolar epithelium in the adult lung, the staining patterns identified cells expressing CAT as most likely alveolar type II and Clara cells.
In summary, our studies have shown that the Ϫ236/ ϩ39-bp region of the rabbit SP-B gene contains the cis-DNA elements necessary for alveolar type II-and bronchiolar (Clara) cell-specific expression and that the Ϫ730/Ϫ236-bp region contains elements that enhance the expression of the gene. Our data have also indicated that the Ϫ2,176/Ϫ730-bp SP-B region may contain elements that repress promoter activity. It remains to be determined whether cis-DNA elements and interacting trans-acting factors that have been identified as important for SP-B promoter function in vitro are also necessary for specifying spatial and temporal expression of the SP-B gene in transgenic mice.
